Alessandro Carugo

4.6k total citations
17 papers, 362 citations indexed

About

Alessandro Carugo is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Alessandro Carugo has authored 17 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Alessandro Carugo's work include Cancer, Hypoxia, and Metabolism (4 papers), Cancer Genomics and Diagnostics (4 papers) and Epigenetics and DNA Methylation (3 papers). Alessandro Carugo is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), Cancer Genomics and Diagnostics (4 papers) and Epigenetics and DNA Methylation (3 papers). Alessandro Carugo collaborates with scholars based in United States, Italy and Netherlands. Alessandro Carugo's co-authors include Giulio Draetta, Timothy P. Heffernan, Christopher A. Bristow, Michael Peoples, Angela K. Deem, Rosalba Minelli, Don L. Gibbons, Jared J. Fradette, Akira Inoue and Scott Kopetz and has published in prestigious journals such as Nature Communications, Cancer Research and Oncogene.

In The Last Decade

Alessandro Carugo

16 papers receiving 360 citations

Peers

Countries citing papers authored by Alessandro Carugo

Since Specialization

Citations

This map shows the geographic impact of Alessandro Carugo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandro Carugo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandro Carugo more than expected).

Fields of papers citing papers by Alessandro Carugo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessandro Carugo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandro Carugo. The network helps show where Alessandro Carugo may publish in the future.

Co-authorship network of co-authors of Alessandro Carugo

This figure shows the co-authorship network connecting the top 25 collaborators of Alessandro Carugo. A scholar is included among the top collaborators of Alessandro Carugo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandro Carugo. Alessandro Carugo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Targeting Glucose Metabolism Sensitizes Pancreatic Cancer to MEK Inhibition 2021 ·Cancer Research ·Yan Liang, Bo Tu, Jun Yao, Jing Gong, Alessandro Carugo, Christopher A. Bristow, Qiuyun Wang, Cihui Zhu, Bingbing Dai, Ya’an Kang, Leng Han, Ningping Feng, (unknown), Jason B. Fleming, Timothy P. Heffernan, Wantong Yao, Haoqiang Ying	30
2	Combined inhibition of DDR1 and CDK4/6 induces synergistic effects in ER-positive, HER2-negative breast cancer with PIK3CA/AKT1 mutations 2021 ·Oncogene ·Maryam Shariati, Kurt W. Evans, Xiaofeng Zheng, Christopher A. Bristow, Patrick Kwok‐Shing Ng, (unknown), Coya Tapia, Fei Yang, Alessandro Carugo, Timothy P. Heffernan, Michael Peoples, Debu Tripathy, Funda Meric‐Bernstam	17
3	Targeting CDK4 overcomes EMT-mediated tumor heterogeneity and therapeutic resistance in KRAS-mutant lung cancer 2021 ·JCI Insight ·(unknown), Jessica Konen, B. Leticia Rodriguez, Jared J. Fradette, Joshua K. Ochieng, Lixia Diao, Jing Wang, Wei Lü, (unknown), Harsh Vardhan Batra, Maria Gabriela Raso, Michael Peoples, Rosalba Minelli, Alessandro Carugo, Christopher A. Bristow, Don L. Gibbons	14
4	Abstract 985: BI 905711 selectively induces apoptosis and anti-tumor response in TRAILR2/CDH17- expressing pancreatic cancer models 2021 ·Cancer Research ·Jing Han, (unknown), Mikhila Mahendra, Joseph R. Daniele, Christopher A. Bristow, Justin K. Huang, Alessandro Carugo, Robert A. Mullinax, (unknown), Ningping Feng, (unknown), Norbert Schweifer, Paolo Chetta, Juan Manuel García‐Martínez, Frank Hilberg, Christopher P. Vellano, Timothy P. Heffernan, Joseph R. Marszalek	1
5	Synthetic Lethality Screening Highlights Colorectal Cancer Vulnerability to Concomitant Blockade of NEDD8 and EGFR Pathways 2021 ·Cancers ·(unknown), Simona Punzi, Consalvo Petti, Rosalba Minelli, Michael Peoples, Christopher A. Bristow, Valentina Vurchio, Alessia Corrado, Alberto Bragoni, Caterina Marchiò, Andrea Bertotti, Livio Trusolino, Alberto Bardelli, Claudio Isella, Alessandro Carugo, Giulio Draetta, Enzo Médico	10
6	Abstract 87: Asparagine synthetase (ASNS) expression predicts response to the GLS1 inhibitor IPN60090 in ovarian cancer through selective modulation of redox homeostasis 2021 ·Cancer Research ·Nakia D. Spencer, Christopher A. Bristow, (unknown), Meredith A. Miller, Alessandro Carugo, Angela L. Harris, Rosalba Minelli, (unknown), Qing Chang, Michael Soth, (unknown), John N. Weinstein, Philip L. Lorenzi, Jinsong Liu, Wei‐Lien Wang, Timothy A. Yap, Giulio Draetta, Philip Jones, Timothy P. Heffernan, Jeffrey J. Kovacs	1
7	ZEB1/NuRD complex suppresses TBC1D2b to stimulate E-cadherin internalization and promote metastasis in lung cancer 2019 ·Nature Communications ·(unknown), Étienne Coyaud, Samrat T. Kundu, David H. Peng, Sabrina A. Stratton, (unknown), (unknown), Jared J. Fradette, Rosalba Minelli, Michael Peoples, Alessandro Carugo, Fengju Chen, Christopher A. Bristow, Jeffrey J. Kovacs, Michelle Barton, Tim Heffernan, Chad J. Creighton, Brian Raught, Don L. Gibbons	73
8	WDR5 inhibition halts metastasis dissemination by repressing the mesenchymal phenotype of breast cancer cells 2019 ·Breast Cancer Research ·Simona Punzi, Chiara Balestrieri, (unknown), Daniela Bossi, Gaetano Ivan Dellino, Elena Gatti, Giancarlo Pruneri, Carmen Criscitiello, (unknown), (unknown), Alessandro Carugo, Giuseppe Curigliano, Gioacchino Natoli, Pier Giuseppe Pelicci, Luisa Lanfrancone	26
9	The Many Facets of Tumor Heterogeneity: Is Metabolism Lagging Behind? 2019 ·Cancers ·Sara Loponte, Sara Lovisa, Angela K. Deem, Alessandro Carugo, Andrea Viale	25
10	Current and Future Horizons of Patient-Derived Xenograft Models in Colorectal Cancer Translational Research 2019 ·Cancers ·Akira Inoue, Angela K. Deem, Scott Kopetz, Timothy P. Heffernan, Giulio Draetta, Alessandro Carugo	37
11	Ntrk1 Promotes Resistance to PD-1 Checkpoint Blockade in Mesenchymal Kras/p53 Mutant Lung Cancer 2019 ·Cancers ·Jessica Konen, B. Leticia Rodriguez, Jared J. Fradette, Laura Gibson, (unknown), Rosalba Minelli, Michael Peoples, Jeffrey J. Kovacs, Alessandro Carugo, Christopher A. Bristow, Timothy P. Heffernan, Don L. Gibbons	24
12	BRCA1 identified as a modulator of temozolomide resistance in P53 wild-type GBM using a high-throughput shRNA-based synthetic lethality screening. 2019 ·PubMed ·Jie Ding, Shaofang Wu, Chen Zhang, (unknown), Emmanuel Martínez-Ledesma, Feng Gao, (unknown), Xiaolong Li, Christopher A. Bristow, Alessandro Carugo, Dimpy Koul, WK Alfred Yung	8
13	ZEB1 suppression sensitizes KRAS mutant cancers to MEK inhibition by an IL17RD-dependent mechanism 2019 ·Science Translational Medicine ·David H. Peng, Samrat T. Kundu, Jared J. Fradette, Lixia Diao, Pan Tong, Lauren A. Byers, Jing Wang, Jaime Rodriguez Canales, Pamela Villalobos, Barbara Mino, Yanan Yang, Rosalba Minelli, Michael Peoples, Christopher A. Bristow, Timothy P. Heffernan, Alessandro Carugo, Ignacio I. Wistuba, Don L. Gibbons	39
14	Academic Discovery of Anticancer Drugs: Historic and Future Perspectives 2018 ·Alessandro Carugo, Giulio Draetta	22
15	Abstract 414: Identifying selective vulnerabilities in colorectal cancer molecular subtypes using in vivo functional genomic screens 2017 ·Cancer Research ·Akira Inoue, Bahar Salimian Rizi, Alessandro Carugo, Sahil Seth, Christopher A. Bristow, Giannicola Genovese, Andrea Viale, David G. Menter, Scott Kopetz, Giulio Draetta	1
16	Abstract IA12: An in vivo high throughput shRNA screening platform for identifying ways to target genomic alterations 2017 ·Clinical Cancer Research ·Tongxin Xie, (unknown), (unknown), Liang Yang, Jiping Wang, Sahil Seth, Alessandro Carugo, Christopher A. Bristow, Frederick S. Robinson, Michael Peoples, Heath D. Skinner, Jeffrey N. Myers, Curtis R. Pickering, Mitchell J. Frederick	0
17	RNAi screens identify CHD4 as an essential gene in breast cancer growth 2016 ·Oncotarget ·(unknown), Simona Punzi, Angelo Cicalese, Lorenzo Fornasari, Laura Furia, Laura Riva, Alessandro Carugo, Giuseppe Curigliano, Carmen Criscitiello, Giancarlo Pruneri, Pier Giuseppe Pelicci, Mario Faretta, Daniela Bossi, Luisa Lanfrancone	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact